Three-Dimensional Bioprinting of Organoid-Based Scaffolds (OBST) for Long-Term Nanoparticle Toxicology Investigation
Gerbolés, Amparo Guerrero, Galetti, Maricla, Rossi, Stefano, Lo Muzio, Francesco Paolo, Pinelli, Silvana, Delmonte, Nicola, Caffarra Malvezzi, Cristina, Macaluso, Claudio, Miragoli, Michele, Foresti, Ruben
Published in International journal of molecular sciences (01.04.2023)
Published in International journal of molecular sciences (01.04.2023)
Get full text
Journal Article
Dual Inhibition of CDK4/6 and PI3K/AKT/mTOR Signaling Impairs Energy Metabolism in MPM Cancer Cells
Bonelli, Mara, Terenziani, Rita, Zoppi, Silvia, Fumarola, Claudia, La Monica, Silvia, Cretella, Daniele, Alfieri, Roberta, Cavazzoni, Andrea, Digiacomo, Graziana, Galetti, Maricla, Petronini, Pier Giorgio
Published in International journal of molecular sciences (21.07.2020)
Published in International journal of molecular sciences (21.07.2020)
Get full text
Journal Article
A New ABCB1 Inhibitor Enhances the Anticancer Effect of Doxorubicin in Both In Vitro and In Vivo Models of NSCLC
Adorni, Maria Pia, Galetti, Maricla, La Monica, Silvia, Incerti, Matteo, Ruffoni, Alessandro, Elviri, Lisa, Zanotti, Ilaria, Papotti, Bianca, Cavallo, Delia, Alfieri, Roberta, Petronini, Pier Giorgio, Bernini, Franco
Published in International journal of molecular sciences (04.01.2023)
Published in International journal of molecular sciences (04.01.2023)
Get full text
Journal Article
Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models
La Monica, Silvia, Vacondio, Federica, Eltayeb, Kamal, Lodola, Alessio, Volta, Francesco, Viglioli, Martina, Ferlenghi, Francesca, Galvani, Francesca, Galetti, Maricla, Bonelli, Mara, Fumarola, Claudia, Cavazzoni, Andrea, Flammini, Lisa, Verzè, Michela, Minari, Roberta, Petronini, Pier Giorgio, Tiseo, Marcello, Mor, Marco, Alfieri, Roberta
Published in Scientific reports (18.03.2024)
Published in Scientific reports (18.03.2024)
Get full text
Journal Article
Effect of ABCG2/BCRP Expression on Efflux and Uptake of Gefitinib in NSCLC Cell Lines
Galetti, Maricla, Petronini, Pier Giorgio, Fumarola, Claudia, Cretella, Daniele, La Monica, Silvia, Bonelli, Mara, Cavazzoni, Andrea, Saccani, Francesca, Caffarra, Cristina, Andreoli, Roberta, Mutti, Antonio, Tiseo, Marcello, Ardizzoni, Andrea, Alfieri, Roberta R
Published in PloS one (04.11.2015)
Published in PloS one (04.11.2015)
Get full text
Journal Article
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC
La Monica, Silvia, Minari, Roberta, Cretella, Daniele, Flammini, Lisa, Fumarola, Claudia, Bonelli, Mara, Cavazzoni, Andrea, Digiacomo, Graziana, Galetti, Maricla, Madeddu, Denise, Falco, Angela, Lagrasta, Costanza Annamaria, Squadrilli, Anna, Barocelli, Elisabetta, Romanel, Alessandro, Quaini, Federico, Petronini, Pier Giorgio, Tiseo, Marcello, Alfieri, Roberta
Published in Journal of experimental & clinical cancer research (28.05.2019)
Published in Journal of experimental & clinical cancer research (28.05.2019)
Get full text
Journal Article
A Photoactive Supramolecular Complex Targeting PD-L1 Reveals a Weak Correlation between Photoactivation Efficiency and Receptor Expression Levels in Non-Small-Cell Lung Cancer Tumor Models
Delcanale, Pietro, Alampi, Manuela Maria, Mussini, Andrea, Fumarola, Claudia, Galetti, Maricla, Petronini, Pier Giorgio, Viappiani, Cristiano, Bruno, Stefano, Abbruzzetti, Stefania
Published in Pharmaceutics (01.12.2023)
Published in Pharmaceutics (01.12.2023)
Get full text
Journal Article
Acquired BRAF G469A Mutation as a Resistance Mechanism to First-Line Osimertinib Treatment in NSCLC Cell Lines Harboring an EGFR Exon 19 Deletion
La Monica, Silvia, Minari, Roberta, Cretella, Daniele, Bonelli, Mara, Fumarola, Claudia, Cavazzoni, Andrea, Galetti, Maricla, Digiacomo, Graziana, Riccardi, Federica, Petronini, Pier Giorgio, Tiseo, Marcello, Alfieri, Roberta
Published in Targeted oncology (01.10.2019)
Published in Targeted oncology (01.10.2019)
Get full text
Journal Article
Simultaneous Combination of the CDK4/6 Inhibitor Palbociclib With Regorafenib Induces Enhanced Anti-tumor Effects in Hepatocarcinoma Cell Lines
Digiacomo, Graziana, Fumarola, Claudia, La Monica, Silvia, Bonelli, Mara A., Cretella, Daniele, Alfieri, Roberta, Cavazzoni, Andrea, Galetti, Maricla, Bertolini, Patrizia, Missale, Gabriele, Petronini, Pier Giorgio
Published in Frontiers in oncology (23.09.2020)
Published in Frontiers in oncology (23.09.2020)
Get full text
Journal Article
Subchronic exposure to titanium dioxide nanoparticles modifies cardiac structure and performance in spontaneously hypertensive rats
Rossi, Stefano, Savi, Monia, Mazzola, Marta, Pinelli, Silvana, Alinovi, Rossella, Gennaccaro, Laura, Pagliaro, Alessandra, Meraviglia, Viviana, Galetti, Maricla, Lozano-Garcia, Omar, Rossini, Alessandra, Frati, Caterina, Falco, Angela, Quaini, Federico, Bocchi, Leonardo, Stilli, Donatella, Lucas, Stéphane, Goldoni, Matteo, Macchi, Emilio, Mutti, Antonio, Miragoli, Michele
Published in Particle and fibre toxicology (24.06.2019)
Published in Particle and fibre toxicology (24.06.2019)
Get full text
Journal Article
Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK–mTORC1 signaling
Fumarola, Claudia, Caffarra, Cristina, La Monica, Silvia, Galetti, Maricla, Alfieri, Roberta R., Cavazzoni, Andrea, Galvani, Elena, Generali, Daniele, Petronini, Pier Giorgio, Bonelli, Mara A.
Published in Breast cancer research and treatment (01.08.2013)
Published in Breast cancer research and treatment (01.08.2013)
Get full text
Journal Article
CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells
Digiacomo, Graziana, Fumarola, Claudia, La Monica, Silvia, Bonelli, Mara, Cavazzoni, Andrea, Galetti, Maricla, Terenziani, Rita, Eltayeb, Kamal, Volta, Francesco, Zoppi, Silvia, Bertolini, Patrizia, Missale, Gabriele, Alfieri, Roberta, Petronini, Pier Giorgio
Published in Frontiers in oncology (22.07.2022)
Published in Frontiers in oncology (22.07.2022)
Get full text
Journal Article
Overcoming acquired resistance to letrozole by targeting the PI3K/AKT/mTOR pathway in breast cancer cell clones
Cavazzoni, Andrea, Bonelli, Mara A, Fumarola, Claudia, La Monica, Silvia, Airoud, Kinda, Bertoni, Ramona, Alfieri, Roberta R, Galetti, Maricla, Tramonti, Stefano, Galvani, Elena, Harris, Adrian L, Martin, Lesley-Ann, Andreis, Daniele, Bottini, Alberto, Generali, Daniele, Petronini, Pier Giorgio
Published in Cancer letters (01.10.2012)
Published in Cancer letters (01.10.2012)
Get full text
Journal Article
Expanding the Arsenal of FGFR Inhibitors: A Novel Chloroacetamide Derivative as a New Irreversible Agent With Anti-proliferative Activity Against FGFR1-Amplified Lung Cancer Cell Lines
Fumarola, Claudia, Bozza, Nicole, Castelli, Riccardo, Ferlenghi, Francesca, Marseglia, Giuseppe, Lodola, Alessio, Bonelli, Mara, La Monica, Silvia, Cretella, Daniele, Alfieri, Roberta, Minari, Roberta, Galetti, Maricla, Tiseo, Marcello, Ardizzoni, Andrea, Mor, Marco, Petronini, Pier Giorgio
Published in Frontiers in oncology (2019)
Published in Frontiers in oncology (2019)
Get full text
Journal Article
Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance
Cretella, Daniele, Saccani, Francesca, Quaini, Federico, Frati, Caterina, Lagrasta, Costanza, Bonelli, Mara, Caffarra, Cristina, Cavazzoni, Andrea, Fumarola, Claudia, Galetti, Maricla, La Monica, Silvia, Ampollini, Luca, Tiseo, Marcello, Ardizzoni, Andrea, Petronini, Pier Giorgio, Alfieri, Roberta R
Published in Molecular cancer (05.06.2014)
Published in Molecular cancer (05.06.2014)
Get full text
Journal Article
Gefitinib inhibits invasive phenotype and epithelial-mesenchymal transition in drug-resistant NSCLC cells with MET amplification
La Monica, Silvia, Caffarra, Cristina, Saccani, Francesca, Galvani, Elena, Galetti, Maricla, Fumarola, Claudia, Bonelli, Mara, Cavazzoni, Andrea, Cretella, Daniele, Sirangelo, Rita, Gatti, Rita, Tiseo, Marcello, Ardizzoni, Andrea, Giovannetti, Elisa, Petronini, Pier Giorgio, Alfieri, Roberta R
Published in PloS one (22.10.2013)
Published in PloS one (22.10.2013)
Get full text
Journal Article
Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines
Cavazzoni, Andrea, Alfieri, Roberta R, Cretella, Daniele, Saccani, Francesca, Ampollini, Luca, Galetti, Maricla, Quaini, Federico, Graiani, Gallia, Madeddu, Denise, Mozzoni, Paola, Galvani, Elena, La Monica, Silvia, Bonelli, Mara, Fumarola, Claudia, Mutti, Antonio, Carbognani, Paolo, Tiseo, Marcello, Barocelli, Elisabetta, Petronini, Pier Giorgio, Ardizzoni, Andrea
Published in Molecular cancer (12.12.2012)
Published in Molecular cancer (12.12.2012)
Get full text
Journal Article
Metabolism of the EGFR tyrosin kinase inhibitor gefitinib by cytochrome P450 1A1 enzyme in EGFR-wild type non small cell lung cancer cell lines
Alfieri, Roberta R, Galetti, Maricla, Tramonti, Stefano, Andreoli, Roberta, Mozzoni, Paola, Cavazzoni, Andrea, Bonelli, Mara, Fumarola, Claudia, La Monica, Silvia, Galvani, Elena, De Palma, Giuseppe, Mutti, Antonio, Mor, Marco, Tiseo, Marcello, Mari, Ettore, Ardizzoni, Andrea, Petronini, Pier Giorgio
Published in Molecular cancer (23.11.2011)
Published in Molecular cancer (23.11.2011)
Get full text
Journal Article
Novel Irreversible Epidermal Growth Factor Receptor Inhibitors by Chemical Modulation of the Cysteine-Trap Portion
Carmi, Caterina, Cavazzoni, Andrea, Vezzosi, Stefano, Bordi, Fabrizio, Vacondio, Federica, Silva, Claudia, Rivara, Silvia, Lodola, Alessio, Alfieri, Roberta R, La Monica, Silvia, Galetti, Maricla, Ardizzoni, Andrea, Petronini, Pier Giorgio, Mor, Marco
Published in Journal of medicinal chemistry (11.03.2010)
Published in Journal of medicinal chemistry (11.03.2010)
Get full text
Journal Article
Epidermal growth factor receptor tyrosine kinase inhibitors: current status and future perspectives in the development of novel irreversible inhibitors for the treatment of mutant non-small cell lung cancer
Galvani, Elena, Alfieri, Roberta, Giovannetti, Elisa, Cavazzoni, Andrea, La Monica, Silvia, Galetti, Maricla, Fumarola, Claudia, Bonelli, Mara, Mor, Marco, Tiseo, Marcello, Peters, Godefridus J, Petronini, Pier Giorgio, Ardizzoni, Andrea
Published in Current pharmaceutical design (01.02.2013)
Published in Current pharmaceutical design (01.02.2013)
Get more information
Journal Article